Abstract
According to guidelines, total ischemic time for homografts at processing must be kept short to avoid degeneration. Many homografts are discarded due to practical inability to finish all steps from procurement to cryopreservation within the time limit. Although, several studies have shown that homografts with prolonged ischemic time show adequate quality and performance. Twenty aortic and 12 pulmonary homografts were collected and biopsies were retrieved at preparation (day 0) and after 1, 2, 3, 4, 7, 14, 21, 28, and 60 days in antibiotic decontamination at 4 °C. Biopsies were prepared for light microscopy (LM) and transmission electron microscopy (TEM). Assessment generated scores for cells, elastin, and collagen. Relative differences between times were compared with Wilcoxon signed rank test. Bonferroni corrected p value of 0.0056 was considered significant. LM could only reveal decrease in cell count at 60 days in aortic homografts, no other differences was detected. TEM showed affected cell appearance in day 3 and day 4 and beyond for aortic and pulmonary homografts respectively. Elastin appearance was affected at day 60 for aortic and day 21 for pulmonary homografts. Collagen appearance was affected at day 28 for aortic homografts, with no significant differences in pulmonary homografts. Cell degeneration starts early after homograft procurement, but elastic and collagen fibers are more resistant to degeneration. Overall structure integrity as seen in LM was not affected at all, while TEM could reveal small degeneration signs in individual elastic fibers and collagen bundles at 21 and 28 days respectively.
Similar content being viewed by others
Introduction
Cardiovascular homografts are one of the preferred heart valves used in reconstruction of the right ventricular outflow tract in congenital heart disease (Baumgartner et al. 2021). Long-term survival after implantation of homografts are excellent, but heart valve longevity is limited (Skoglund et al. 2017; Meijer et al. 2019; Romeo et al. 2019). Homografts are retrieved from human donor hearts, where tissue banks conduct processing and storage of these tissues.
To ensure homograft quality, European tissue banks adhere to guidelines developed from the European Directorate for the Quality of Medicine and Health Care (Doerr 2022). One important consideration in homograft processing is the maximum total ischemic time, i.e., time from donor circulatory arrest until cryopreservation of the homograft. Current guidelines recommend a maximum of 72 h of total ischemic time, with a maximum of six hours of warm ischemic time, and where at least 24 h must be allowed for antibiotic decontamination prior to cryopreservation. This leaves less than 48 h for the tissue bank to retrieve the tissue, transport it to the tissue bank, prepare the heart valves, and cryopreserve them after antibiotic decontamination. If strictly adhering to these guidelines, many homografts will be lost due to practical reasons (Botes et al. 2012).
Short ischemic time intend to keep homograft quality and prevent adverse events after implantation, but studies indicate that it would be safe to implant homografts with prolonged ischemic time (Meyns et al. 2005; Kalfa et al. 2011; Axelsson and Malm 2018; Bester et al. 2018). Looking at the homograft structure after prolonged ischemic time, it is shown that cellular viability decreases (Wallace et al. 1992; Niwaya et al. 1995; Gall et al. 1998). When the cell is exposed for starvation and degeneration, chromatin start to condensate within the cell nuclei (Burgoyne 1999), cell content starts to vacuolize and cells starts to shrink and detach from surrounding tissue (Wallace et al. 1992; Kristek et al. 1993).
Except for cells, the homograft is composed of extracellular matrix where elastin and collagen are the main components of the aorta and the pulmonary artery, providing strength and elasticity to the tissue (Burkert et al. 2021). Healthy vessels express lower content of collagen compared to vessels from older individuals and vessels exposed to hypertension, with intact elastic fibers (without fragmentation) and surrounding fibrillin to anchor mature elastin fibers to surrounding tissue (Kielty et al. 2002; Jordão et al. 2011; Halushka et al. 2016). Typical elastin degeneration signs are increased complexity, splitting, fragmentation and thinning of the fiber (Dingemans et al. 2006; Halushka et al. 2016). Collagen degeneration signs have previously been shown in vascular diseases such as aortic aneurysm and hypertension, and consist of increased waviness and disrupted fiber orientation, as well as disrupted D-bands with reduced contrast (Jones et al. 2020). So far, studies have shown that mechanical and morphological properties of the extracellular matrix of the homograft vessel walls and cusps seem to keep intact after prolonged cold ischemic time prior to organ harvest (Smit et al. 2015; Bester et al. 2018; Fabian et al. 2022). Forensic studies have shown that tissues with extracellular matrix that is rich in collagen and/or elastin, such as blood vessels, are resistant to both autolytic degeneration and microbiological decomposition and that adequate cooling slow the process even further (Cocariu et al. 2016; Javan et al. 2019).
The aim of this study was to investigate homograft tissue integrity and ultrastructures at different ischemic times, ranging from 0 to 60 days. The objective was to determine if it is possible to find an exact time point when the homograft starts to degenerate with signs of tissue integrity dissolution and quality impairment.
Materials and methods
Ethical statement
The Regional Ethical Review Board in Lund, Sweden, approved the study (Dnr 2017/133 and Dnr 2018/568).
Homografts
Homografts were collected from the Tissue Bank in Lund during 2019–2022. Inclusion criteria were homografts that could not be used for transplantation due to structural impairment such as valve fenestrations, donor aged 18–65, and donors with donation after brain death (DBD). DBD donors were chosen to avoid impact from different ischemic times and warm ischemia prior to heart explantation, which is the case in non-heart beating donors. Atherosclerosis in the vessel wall was accepted if it was scarcely distributed, with sufficient healthy vessel left for biopsies.
Homografts were prepared according to regular routines. If structural impairment was found that excluded the homograft from transplantation, it was evaluated for inclusion in the study. If inclusion criteria were met, first biopsies were retrieved in conjunction with the preparation procedure, prior to antibiotic decontamination. Biopsies were retrieved from the vessel wall of the homograft and defined as “Day 0”. The homograft was then put in a regular antibiotic solution (200 ml Medium199 Earle’s salt, Vancomycin (100 mg), Gensumycin (106 mg) and Amphotericin B (50 mg)) and stored at 4 °C according to standard protocols. Additional biopsies were retrieved after 1, 2, 3, 4, 7, 14, 21, 28 and 60 days in the antibiotic solution. The full vessel wall of the homograft had to be used to be able to collect all biopsies (in aortic homografts including vessel just distal to the sinuses until the proximal aortic arch and in pulmonary homografts including vessel from just distal to the sinuses until the pulmonary bifurcation).
Light microscopy
At each time, three biopsies with the size of 0.5 × 0.5 cm were retrieved from the homograft vessel wall. Samples were fixed in formalin at 4 °C directly after collection. Samples were dehydrated with increasing concentrations of ethanol and xylene and then embedded in paraffin under vacuum. Sections of 3,5 mm were placed on slides in heated distilled water and then dried overnight in a heating cabinet. Sections were stained with erythrosine saffron for inspection of cell nuclei, elastica van Gieson for elastin fibers and azan for collagen fibers. Samples were scanned with NanoZoomer-SQ Digital slide scanner (Hamamatsu Photonics, Hamamatsu-city, Japan) and assessed at a computer screen through NDP.view2 Image viewing software (Hamamatsu Photonics, Hamamatsu-city, Japan). Analysis was conducted with 20–40 × magnification.
Transmission electron microscopy
At each time point, one biopsy with the size om 0,5 × 0,1 cm was retrieved from the homograft vessel wall. Biopsies were pre-fixed in 2% paraformaldehyde and 2% glutaraldehyde for 1–24 h and then rinsed in 0,1 Sorensen’s Phosphate Buffer. Samples were fixed with 1% OsO4 for one hour followed by dehydration with increasing concentrations of acetone. After dehydration, samples were impregnated and embedded in Epon, followed by polymerization in Epon for 48 h at 60 °C. Thin sections of 60 nm were sliced with Diatome diamond knife in Leica EM UC7 ultratome and sections were mounted on Maxtaform H5 formvar coated copper grid. Grids were contrasted with 4% uranylacetat for 20 min in 38 °C and 1% leadcitrate for 2 min in room temperature. Samples were examined with FEI Tecnai biotwin 120 kV microscope and images were obtained with Olympus veleta 2 × 2 k camera.
Morphological interpretation
Light microscopy (LM) and transmission electron microscopy (TEM) samples were assessed separately with two different protocols. Cells, elastic fibers, and collagen fibers were analyzed separately in both modalities. Aortic and pulmonary homografts were analyzed in two separate groups.
Light microscopy
Evaluation of LM samples was blinded, the evaluator did not know which day the samples were from. One evaluator assessed all samples. A second evaluator assessed 20% of the samples to validate the protocol and check for inter-rater reliability.
Cells were evaluated with two different categories, cell count and cell nuclei appearance. Three circles with a radius of 100 µm were placed in the media of the vessel wall, one close to the endothelial area, one in the middle of the media and one close to the adventitial area. Cell count was calculated as a continuous variable, by counting total cell count within each circle (Fig. 1A). Cell nuclei appearance was evaluated within the defined circles as well. Cell nuclei was defined as normal, pyknotic or karyolitic in each circle, and given separate scores of 1–3 depending on the dominated cell type (Fig. 2) (Table 1).
Elastin was evaluated as a continuous variable, counting the number of intact elastin fibers. Two areas of 0.8 mm2 (aortic) or 0.4 mm2 (pulmonary) were chosen at random for each sample. Smaller area was chosen for pulmonary homografts since their vessel wall was thinner. Within the area, all intact elastin fibers > 100 µm (aortic) or > 50 µm (pulmonary) were counted (Fig. 1B-C). Different lengths were chosen since the normal aorta express more and longer elastic fibers compared to the normal pulmonary artery. Longer fibers were given a higher score (Table 1).
Collagen was evaluated as a categorical variable. Two separate areas of the sample were evaluated, and each area was given a score from 5 (normal) to 1 (complete destruction) (Table 1) (Fig. 3).
A summary of the evaluation protocol is shown in Table 1.
Transmission electron microscopy
TEM was used to evaluate ultrastructures of the homografts. The evaluation was not blinded. One evaluator assessed all samples. Five cells, five elastin fibers and five areas with collagen were inspected and evaluated separately within each sample.
Cell appearance was evaluated by chromatin appearance, cell nuclei membrane and cell shrinkage (Fig. 4). Elastin appearance was evaluated by fiber structure and fragmentation, damage within the fibers and presence of surrounding fibrillin (Fig. 5). Collagen appearance was evaluated by collagen bundle structure and orientation, shrinkage of bundles and presence of typical D-banding pattern (Fig. 6). A summary of the evaluation protocol is shown in Table 2.
Statistical analysis
Results are presented as medians with interquartile range.
Differences in score from morphological analysis was analyzed with Wilcoxon signed rank test for paired data. For LM, day 0 was used as reference day and all other groups were compared separately to the result from day 0. If day 0 was missing, day 1 was used as reference day. Score at day 0 were set to 1, and relative difference between groups were calculated, to minimize impact by differences between different homografts. For TEM, day 1 was used as reference day. Due to practical issues, proper material for TEM (formaldehyde) could not be retrieved at day 0 for all samples. To minimize impact from missing data, day 1 was used as reference day instead. If both day 0 and day 1 was missing, day 2 was used as reference day. Post-hoc test for multiple comparisons were conducted with the Bonferroni correction.
Correlation between the result from the two different evaluators in LM were analyzed with intraclass correlation coefficient (ICC) for continuous variables and weighted Cohen’s Kappa for categorical, ordinal variables.
Analyses were performed with Stata Statistical Software (StataCorp. 2017. Release 15. College Station, TX: StataCorp LLC, USA).
Main outcome was relative differences in score for cells, elastin and collagen between the reference day and longer time intervals.
Results
Homografts
Donor and homograft characteristics are presented in Table 3. Since all donors were DBDs, there was no ischemic time prior to explantation. Explantation to preparation time is defined as time from heart explantation until homograft procurement in the tissue bank. During this period the heart is stored in a cold environment, without antibiotic treatment. Only one aortic and one pulmonary homograft had an explantation to preparation time that exceeded 48 h.
Morphological interpretation
Each category was analyzed nine different times (each time point compared separately to the reference time point), resulting in a Bonferroni corrected p value of 0.0056.
Light microscopy
Each homograft (n = 32) generated biopsies from 10 different times. Sample from day 0 was missing in two aortic homografts. Sample from day 60 was missing in one pulmonary homograft. In total, 317 samples were analyzed, and 60 samples (19%) were randomly selected for blinded evaluation by an additional evaluator to assess validity of the protocol. Result from analysis of inter-rater reliability is shown in Table 4. All four categories have a correlation between 75 and 95%, considered substantial to almost perfect agreement according to Landis and Koch (1977).
Result from evaluation of samples in LM are shown in Table 5 for aortic homografts and Table 6 for pulmonary homografts. When using Bonferroni corrected p-value, only cell count showed a significant difference when comparing day 0 to day 60 in aortic homografts.
Transmission electron microscopy
Samples from day 0 was missing from 11 aortic and seven pulmonary homografts. Samples from day 1 was missing from two aortic and one pulmonary homograft. Samples from day 21 was missing from one aortic and one pulmonary homograft. Samples from day 60 was missing from one pulmonary homograft. In total, 296 samples were analyzed.
Result from evaluation of samples in TEM are shown in Table 7 for aortic homografts and Table 8 for pulmonary homografts. For aortic homografts, all samples from day 3 and beyond showed significantly more cell degeneration compared to day 1. For pulmonary homografts, all samples from day 4 and beyond showed significantly more cell degeneration compared to day 1. Elastin appearance show significantly more degeneration at day 60 for aortic homografts and at day 21 for pulmonary homografts. Collagen appearance show significantly more degeneration at day 28 for aortic homografts. No significant differences in collagen appearance are shown in pulmonary homografts.
Discussion
This study investigates the presence of autolytic changes in homografts with prolonged cold ischemic time during antibiotic decontamination. It is the first study to investigate the homograft at a total of ten different time points during this step of the homograft processing process. Current guidelines recommend a maximum of 72 h of total ischemic time. This guideline is based on opinion and experience only, although repeated studies have shown good performance of homografts with prolonged total ischemic times (Meyns et al. 2005; Kalfa et al. 2011; Axelsson and Malm 2018; Bester et al. 2018).
In LM, it was difficult to detect any major degeneration of either cells, elastin fibers, or collagen fibers, showing that the overall structural integrity is well preserved at prolonged decontamination time. The only significant difference that could be found was a decrease in cell count at 60 days in aortic homografts. When looking at TEM samples, cells start to degenerate after 3–4 days of antibiotic decontamination with increased condensation of chromatin, dissolving cell nuclei membrane and detachment from surrounding tissue, all findings that can be difficult to detect with LM alone. Other studies confirm that cell viability decrease early, especially in warm ischemic environments (Livi et al. 1987; Niwaya et al. 1995; Gall et al. 1998). Wallace et. al (1992) describe that after 36 h of warm ischemic time, about 30% of the cells show irreversible cell injury. Similar signs of cellular injury can be seen in vascular diseases such as hypertension and atherosclerosis (Okruhlicová et al. 2008), indicating that viable cells could be important for vessel wall function in homografts. Niwaya et al. (1995) could show a negative correlation between cell viability and warm ischemic time. The importance of cell viability for optimal homograft function is not completely clear, but many studies indicate that the recipient will re-populate the tissue if no donor cells are present. Yu et al. (2011) implanted homografts into dogs and could show that after 12 months of implantation, the endothelial surface of the homograft was covered by the recipient’s own cells. Viable fibroblasts could be observed as well, but it was not possible to determine if they were of donor or recipient origin. Hazekamp et. al (1995) have shown that homograft implanted in pigs, explanted after 3–4 months, showed presence of both recipient and donor cells. Mitchell et al. (1995) analyzed explanted homografts from humans (8 h to 9 years after implantation) and could show that homografts implanted for a longer period expressed almost no cellular viability, but a preserved collagen network of donor origin. Studies also suggest that viable donor cells in the homograft could start an immune response in the recipient, which could speed up degeneration of the tissue (Welters et al. 2001; Shaddy and Hawkins 2002). This suggestion is also supported by studies showing promising results when using completely decellularized homografts (Boethig et al. 2019). When implanting decellularized homografts into pigs and explanting them after 15 months, investigation could show population of cells in both vessel and cusps with reendothelialization of the aorta and cusps surfaces and production of new collagen and elastin in the tissue (Gallo et al. 2016). Initial 5- and 10 year follow-up of decellularized homograft implantation in humans have shown promising results, indicating that the recipient does not depend on viable cells from the donor to ensure homograft function (Boethig et al. 2019). Up to this day, there are no clear consensus on whether cell viability is crucial for homograft longevity, but the good performance of completely decellularized homografts indicate that it is not necessary to strive for viable cells prior to cryopreservation.
Degeneration of collagen and elastin structures was less compared to cells. LM analysis could not show any degeneration of elastin or collagen for up to 60 days of cold ischemic time in the antibiotic solution, with preserved tissue structure and integrity. TEM could detect small differences, with detectable collagen degeneration at 28 days in aortic homograft and elastin degeneration at 60 days in aortic and 21 days in pulmonary homografts. It is known that these proteins are resistant to autolytic degeneration which is confirmed by our results (Cocariu et al. 2016; Javan et al. 2019). Similar findings have been demonstrated by others. Livi et al. (1987) investigated 20 homografts (aortic and pulmonary) after 2 and 4 weeks of cold storage in an antibiotic solution and could not see any structural differences in LM compared to the day of harvest. Fabian et al. (2022) investigated 57 homografts prior to implantation, where a majority of samples showed a mild degree of structural degeneration that correlated to higher donor age. However, degeneration was not correlated to prolonged cold ischemic time prior to antibiotic decontamination (12–21 h), neither prolonged antibiotic decontamination (12–21 days). Correlation between degeneration and donor age is well known from the literature (Halushka et al. 2016). Forensic studies of collagen in gingival tissue show that prolonged warm ischemic time (from 2 to 9 days) show a gradual degeneration of tissue with progressive disorientation of collagen bundles, indicating that this in the natural course for autolytic changes in collagen. Although, this process is significantly slowed down if the tissue is cooled (Mazzotti et al. 2019) and signs of collagen disorientation could not be seen until at least 28 days of cold storage in our material. While cells tend to degenerate early, elastin and collagen seem to keep its structural integrity for at least 21 days in cold storage. Still, early signs of collagen and elastin degeneration is subtle, and seem to be difficult to detect with LM alone.
Limitations
Literature describes that previous medical history and increased age has significant impact of the extracellular proteins of the vessel wall (Halushka et al. 2016). Our material had a heterogenous group of donors which could impact the result. Due to limited availability of tissue, especially for pulmonary homografts, the investigated groups were small.
Conclusion
Our material shows evidence of cell degeneration after a total of 3 days of antibiotic decontamination in a cold environment, preceded by a median cold ischemic period of 35–37 h (pulmonary vs. aortic homografts) prior to homograft preparation. Earliest signs of elastin and collagen degeneration could be found after 21 and 28 days respectively, showing high resistance to degenerative processes. Overall structural integrity as seen in LM was not affected at all at 60 days, only TEM could reveal small degeneration signs in individual elastic fibers and collagen bundles. We suggest that homograft decontamination in a cold environment could be prolonged to at least 14 days without affecting the quality of tissue matrix.
Data availability statement
Data is available upon request.
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Abbreviations
- DBD:
-
Donation after brain death
- LM:
-
Light microscopy
- TEM:
-
Transmission electron microscopy
References
Axelsson I, Malm T (2018) Long-term outcome of homograft implants related to donor and tissue characteristics. Ann Thorac Surg 106:165–171. https://doi.org/10.1016/j.athoracsur.2018.03.014
Baumgartner H, De Backer J, Babu-Narayan SV et al (2021) 2020 ESC guidelines for the management of adult congenital heart disease. The task force for the management of adult congenital heart disease of the European society of cardiology (ESC). endorsed by: association for European paediatric and congenital cardiology (AEPC), International society for adult congenital heart disease (ISACHD). Eur Heart J 42:563–645. https://doi.org/10.1093/EURHEARTJ/EHAA554
Bester D, Botes L, van den Heever JJ et al (2018) Cadaver donation: structural integrity of pulmonary homografts harvested 48 h post mortem in the juvenile ovine model. Cell Tissue Bank 19:743–754. https://doi.org/10.1007/s10561-018-9729-7
Boethig D, Horke A, Hazekamp M et al (2019) A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR trial and ESPOIR registry data. Eur J Cardio-thoracic Surg 56:503–509
Botes L, Van Den Heever JJ, Smit FE, Neethling WML (2012) Cardiac allografts: a 24-year South African experience. Cell Tissue Bank 13:139–146. https://doi.org/10.1007/s10561-010-9237-x
Burgoyne LA (1999) The mechanisms of Pyknosis: hypercondensation and death. Exp Cell Res 248:214–222. https://doi.org/10.1006/EXCR.1999.4406
Burkert J, Kochová P, Tonar Z et al (2021) The time has come to extend the expiration limit of cryopreserved allograft heart valves. Cell Tissue Bank 22:161–184
Cocariu EA, Mageriu V, Stăniceanu F et al (2016) Correlations between the autolytic changes and postmortem interval in refrigerated cadavers. Rom J Intern Med 54:105–112. https://doi.org/10.1515/rjim-2016-0012
Crescenzo DG, Hilbert SL, Barrick MK, Corcoran PC, Louis JDS, Messier RH, Hopkins RA (1992) Donor heart valves: electron microscopic and morphometric assessment of cellular injury induced by warm ischemia. J Thorac Cardiovasc Surg 103(2):253–258
Dingemans KP, Teeling P, van der Wal AC, Becker AE (2006) Ultrastructural pathology of aortic dissections in patients with marfan syndrome: comparison with dissections in patients without marfan syndrome. Cardiovasc Pathol 15:203–212. https://doi.org/10.1016/j.carpath.2006.03.004
Doerr P (2022) Guide to the quality and safety of tissues and cells for human application, 5th Edition. European Directorate for the Quality of Medicines & Healthcare
Fabian O, Havova M, Gebauer R et al (2022) Structural integrity and cellular viability of cryopreserved allograft heart valves in right ventricular outflow tract reconstruction correlation of histopathological changes with donor characteristics and preservation times. Braz J Cardiovasc Surg. https://doi.org/10.21470/1678-9741-2020-0710
Gall KL, Smith SE, Willmette CA, O’Brien MF (1998) Allograft heart valve viability and valve-processing variables. Ann Thorac Surg 65:1032–1038. https://doi.org/10.1016/s0003-4975(98)00085-x
Gallo M, Bonetti A, Poser H et al (2016) Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts. Heart Vessels 31:1862–1873. https://doi.org/10.1007/S00380-016-0839-5
Halushka MK, Angelini A, Bartoloni G et al (2016) Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European cardiovascular pathology: II. Noninflammatory degenerative diseases—nomenclature and diagnostic criteria. Cardiovasc Pathol 25:247–257
Hazekamp MG, Koolbergen DR, Braun J et al (1995) In situ hybridization: a new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants. J Thorac Cardiovasc Surg 110:247–257
Javan GT, Finley SJ, Tuomisto S et al (2019) An interdisciplinary review of the thanatomicrobiome in human decomposition. Forensic Sci Med Pathol 15:75–83
Jian-hua Y, Hong-wei G, Shi-qiu S (2011) Quantitative analysis of host cells growing into canine homograft valved aortic and pulmonary artery. Chin Med J 124(9):1422–1426. https://doi.org/10.3760/cma.j.issn.0366-6999.2011.09.025
Jones B, Tonniges JR, Debski A (2020) Collagen fibril abnormalities in human and mice abdominal aortic aneurysm. Acta Biomater 110:129–140. https://doi.org/10.1016/j.actbio.2020.04.022
Jordão MT, Ladd FVL, Coppi AA et al (2011) Exercise training restores hypertension-induced changes in the elastic tissue of the thoracic aorta. J Vasc Res 48:513–524. https://doi.org/10.1159/000329590
Kalfa D, MacÉ L, Metras D, Kreitmann B (2011) How to choose the best available homograft to reconstruct the right ventricular outflow tract. J Thorac Cardiovasc Surg 142:950–953. https://doi.org/10.1016/j.jtcvs.2011.03.005
Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115:2817–2828. https://doi.org/10.1242/JCS.115.14.2817
Kristek F, Török J, Šikulová J (1993) Morphological and functional alterations in endothelium, smooth muscle, and nerve fibers in rabbit aorta after storage at 4 °C. Cryobiology 30:376–385. https://doi.org/10.1006/CRYO.1993.1037
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159. https://doi.org/10.2307/2529310
Livi U, Abdulla AK, Parker R et al (1987) Viability and morphology of aortic and pulmonary homografts: a comparative study. J Thorac Cardiovasc Surg 93:755–760. https://doi.org/10.1016/S0022-5223(19)36357-3
Mazzotti MC, Fais P, Palazzo C et al (2019) Determining the time of death by morphological and immunohistochemical evaluation of collagen fibers in postmortem gingival tissues. Leg Med 39:1–8. https://doi.org/10.1016/j.legalmed.2019.05.002
Meijer FMM, Kies P, Jongbloed MRM et al (2019) Excellent durability of homografts in pulmonary position analysed in a predefined adult group with tetralogy of fallot. Interact Cardiovasc Thorac Surg 28:279–283
Meyns B, Jashari R, Gewillig M et al (2005) Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur J Cardio-Thorac Surg 28:211–216
Mitchell RN, Jonas RA, Schoen FJ (1995) Structure-function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg 60:S108–S113. https://doi.org/10.1016/0003-4975(95)00258-M
Niwaya K, Sakaguchi H, Kawachi K, Kitamura S (1995) Effect of warm ischemia and cryopreservation on cell viability of human allograft valves. Ann Thorac Surg 60:S114–S117. https://doi.org/10.1016/0003-4975(95)00204-X
Okruhlicová L, Dlugošová K, Mitašíková M, Bernátová I (2008) Ultrastructural characteristics of aortic endothelial cells in borderline hypertensive rats exposed to chronic social stress. Physiol Res 57:31–37
Romeo JLR, Mokhles MM, Van De Woestijne P et al (2019) Long-term clinical outcome and echocardiographic function of homografts in the right ventricular outflow tract. Eur J Cardiothorac Surg 55:518–526. https://doi.org/10.1093/ejcts/ezy265
Shaddy RE, Hawkins JA (2002) Immunology and failure of valved allografts in children. Ann Thorac Surg 74(4):1271–1275
Skoglund K, Svensson G, Thilén U et al (2017) Long-term outcome after right ventricle to pulmonary artery conduit surgery and reintervention. Scand Cardiovasc J 51:284–291. https://doi.org/10.1080/14017431.2017.1343492
Smit FE, Bester D, van den Heever JJ et al (2015) Does prolonged post-mortem cold ischemic harvesting time influence cryopreserved pulmonary homograft tissue integrity? Cell Tissue Bank 16:531–544. https://doi.org/10.1007/s10561-015-9500-2
Welters MJP, Oei FBS, Vaessen LMB et al (2001) Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation. Clin Exp Immunol 124:353–358. https://doi.org/10.1046/j.1365-2249.2001.01557.x
Acknowledgements
The authors want to thank the staff at the Tissue Bank in Lund for help with procurement and cryopreservation of homograft samples. We also want to thank the staff at the department of Forensic Medicine in Lund for help with tissue preparation for microscopy.
Funding
Open access funding provided by Lund University. This work was supported by grants from the Swedish Fund of Congenital Heart Defects, the Swedish Odd Fellow Jubilee Foundation, funding for development of tissue donation and procurement from the Swedish National Council of Organs, Tissues, Blood, and Cells, and governmental funding of clinical research within the National Health Services. Conflict of interest: none declared.
Author information
Authors and Affiliations
Contributions
Conceptualization: TM. Formal analysis: IvK, JN. Funding acquisition: IvK, JN, TM. Investigation: IvK, AE, TM. Methodology: all authors. Project administration: IvK, TM. Resources: IvK, AE, JN. Supervision: JN, TM. Validation: AE. Visualization: IvK. Writing—original draft: IvK. Writing—reviewing and editing: all authors.
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
von Konow, I., Eliasson, A., Nilsson, J. et al. Impact of prolonged storage time on homograft ultrastructures: an attempt to find optimal guidelines for homograft processing. Cell Tissue Bank (2024). https://doi.org/10.1007/s10561-024-10127-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10561-024-10127-2